Clinical Trial Update: A Study of Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating albuferon in combination with ribavirin for interferon-treatment experienced chronic hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Albuferon (albuferon)
• Ribavirin (ribavirin)

Snippet

Sponsor: Human Genome Sciences Inc. | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED